DKK 7.0
(1.74%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 7.54 Million DKK | 420.19% |
2022 | 1.45 Million DKK | -61.85% |
2021 | 3.8 Million DKK | -45.14% |
2020 | 6.93 Million DKK | 135.62% |
2019 | 2.94 Million DKK | 21.97% |
2018 | 2.41 Million DKK | 21.76% |
2017 | 1.98 Million DKK | -34.23% |
2016 | 3.01 Million DKK | -0.46% |
2015 | 3.02 Million DKK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 6.76 Million DKK | -10.36% |
2024 Q2 | 6.64 Million DKK | -1.8% |
2023 Q2 | 6.47 Million DKK | 569.18% |
2023 Q4 | 7.54 Million DKK | 4.2% |
2023 Q1 | 967 Thousand DKK | -33.36% |
2023 Q3 | 7.24 Million DKK | 11.95% |
2023 FY | 7.54 Million DKK | 420.19% |
2022 Q1 | 4.02 Million DKK | 5.84% |
2022 FY | 1.45 Million DKK | -61.85% |
2022 Q4 | 1.45 Million DKK | -27.49% |
2022 Q3 | 2 Million DKK | 22.46% |
2022 Q2 | 1.63 Million DKK | -59.4% |
2021 Q3 | 2.85 Million DKK | -10.66% |
2021 Q1 | 2.63 Million DKK | -61.93% |
2021 FY | 3.8 Million DKK | -45.14% |
2021 Q4 | 3.8 Million DKK | 33.44% |
2021 Q2 | 3.19 Million DKK | 20.88% |
2020 Q2 | 4.19 Million DKK | 30.26% |
2020 FY | 6.93 Million DKK | 135.62% |
2020 Q3 | 7.26 Million DKK | 73.26% |
2020 Q4 | 6.93 Million DKK | -4.58% |
2020 Q1 | 3.21 Million DKK | 9.42% |
2019 Q2 | 3.42 Million DKK | 22.33% |
2019 FY | 2.94 Million DKK | 21.97% |
2019 Q4 | 2.94 Million DKK | -15.31% |
2019 Q3 | 3.47 Million DKK | 1.48% |
2019 Q1 | 2.79 Million DKK | 16.02% |
2018 Q1 | 13.49 Million DKK | 581.42% |
2018 FY | 2.41 Million DKK | 21.76% |
2018 Q3 | 3.52 Million DKK | -59.9% |
2018 Q4 | 2.41 Million DKK | -31.59% |
2018 Q2 | 8.79 Million DKK | -34.86% |
2017 Q1 | - DKK | 0.0% |
2017 Q4 | 1.98 Million DKK | 0.0% |
2017 FY | 1.98 Million DKK | -34.23% |
2016 FY | 3.01 Million DKK | -0.46% |
2015 FY | 3.02 Million DKK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ambu A/S | 1.46 Billion DKK | 99.485% |
ChemoMetec A/S | 111.35 Million DKK | 93.222% |
Demant A/S | 21.2 Billion DKK | 99.964% |
GN Store Nord A/S | 21.05 Billion DKK | 99.964% |
Scandinavian Medical Solutions A/S | 89.51 Million DKK | 91.568% |